I-Mab (IMAB), a biotech company, Wednesday said it has appointed Sean Fu as chief executive officer effective November 1, 2024.
Fu has been serving as interim CEO since July 15 following the resignation of previous chief executive Raj Kannan.
Fu has more than 20 years of experience in life sciences industry, leading and developing clinical-stage assets. Most recently, he was an Operating Partner of ABio-X, an incubation platform for life sciences companies.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.